GleamWall
中文EN

XGN EXAGEN INC.

Services-Medical Laboratories · Nasdaq · SEC CIK 1274737 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY13.7%
TTM net income YoY4.6%
TTM EPS YoY18.3%
Revenue 3-yr CAGR11.9%
Net income 3-yr CAGR—

Margins

Gross margin58.7%
Operating margin-20.1%
Net margin-25.1%
FCF margin-18.0%
EBITDA margin-16.6%

Returns

ROE-113.9%
ROA-30.8%
ROIC (approx.)-167.2%
Asset turnover1.22x

Leverage & solvency

Liabilities / assets75.1%
Debt / equity1.66x
Current ratio3.46x
Interest coverage-2.90x

Cash quality & payout

Operating cash flow / net income0.66x
Accruals ratio-10.4%
Payout ratio—
Capex / revenue1.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$18.42M$19.94M$17.31M$16.63M$17.24M$17.20M$15.50M$13.65M
Cost of revenue$7.58M$7.72M$7.10M$7.42M$7.17M$6.81M$6.38M$5.18M
Gross profit$10.84M$12.22M$10.21M$9.21M$10.07M$10.39M$9.12M$8.48M
R&D expense$1.82M$1.43M$1.55M$1.76M$1.73M$1.48M$1.28M$1.66M
SG&A expense$12.83M$12.51M$12.07M$12.42M$11.45M$11.54M$11.20M$10.20M
Operating income-$4.41M-$1.72M-$3.41M-$4.97M-$3.10M-$2.63M-$3.37M-$3.38M
Interest expense$1.20M$1.20M$1.27M$1.33M$1.32M$1.12M$545,000$563,000
Income tax-$1,000$0$36,000$13,000$1,000$37,000$0$12,000
Net income-$6.34M-$3.20M-$3.97M-$4.67M-$7.09M-$4.44M-$3.75M-$3.76M
EBITDA-$3.71M-$1.12M-$2.81M-$4.38M-$2.50M-$2.13M-$2.96M-$2.98M
EPS (basic)-0.25-0.13-0.17—-0.31-0.21-0.20—
EPS (diluted)-0.25-0.13-0.17—-0.31-0.21-0.20—
Weighted avg. shares (diluted)24.85M24.16M23.85M—22.94M21.09M18.56M—
Balance sheet
Cash & equivalents$28.09M$24.59M$21.51M$32.22M$35.85M$30.23M$11.39M$22.24M
Receivables$11.48M$12.41M$15.77M$10.86M$11.09M$14.27M$14.73M$7.83M
Current assets$45.33M$42.86M$43.58M$48.89M$52.59M$50.99M$32.51M$36.45M
PP&E, net$6.06M$6.57M$6.61M$6.94M$7.49M$4.58M$5.03M$5.28M
Total assets$55.35M$51.94M$51.96M$58.02M$62.82M$58.76M$40.29M$44.69M
Current liabilities$13.10M$13.46M$12.56M$14.16M$12.89M$10.29M$13.99M$13.51M
Short-term debt$453,000$517,000$580,000$643,000$680,000$667,000$2.54M$423,000
Long-term debt$22.36M$22.32M$22.29M$22.26M$22.26M$22.31M$18.41M$19.82M
Total debt$22.81M$22.84M$22.87M$22.91M$22.94M$22.98M$20.94M$20.25M
Total liabilities$41.58M$39.72M$37.52M$40.57M$44.69M$37.73M$33.89M$35.15M
Shareholders' equity$13.78M$12.22M$14.43M$17.45M$18.14M$21.03M$6.40M$9.54M
Net debt-$5.28M-$1.75M$1.36M-$9.31M-$12.91M-$7.26M$9.55M-$1.99M
Shares outstanding25.42M24.19M24.09M22.91M22.51M22.00M17.95M17.64M
Cash flow statement
Operating cash flow-$2.58M$3.99M-$10.42M-$3.01M$2.94M-$2.88M-$10.67M$363,000
Capital expenditure$196,000$543,000$228,000$44,000$275,000$209,000$113,000$146,000
Free cash flow-$2.77M$3.44M-$10.64M-$3.06M$2.67M-$3.09M-$10.78M$217,000
Investing cash flow-$196,000-$543,000-$228,000-$35,000-$275,000-$209,000-$107,000-$146,000
Financing cash flow$6.28M-$370,000-$62,000-$384,000$2.95M$21.93M-$64,000-$216,000
Depreciation & amortization$700,000$600,000$600,000$600,000$600,000$500,000$400,000$400,000
Stock-based compensation$1.24M$980,000$655,000$705,000$593,000$443,000$417,000$433,000

Free plan shows the latest 8 periods; Pro shows all 35 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.